Abstract Details
|
Panayiota Petrou
PRESENTER |
No disclosure on file |
| Marc Gotkine, MD (Hadassa University Hospital) | No disclosure on file |
| Jeff Guptill, MD, FAAN (argenx US) | Dr. Guptill has received personal compensation for serving as an employee of argenx. Dr. Guptill has or had stock in argenx. |
| Yael Gothelf | Yael Gothelf, 18041 has received personal compensation for serving as an employee of Brainstorm Cell Therapeutics. |
| No disclosure on file | |
| No disclosure on file | |
| Adi Vaknin-Dembinsky, MD | Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medison Pharma. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for neopharm group. Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for medisone . Dr. Vaknin-Dembinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for alexion. |
| Zohar Argov, MD (Hadassah Hebrew University Medical Center) | No disclosure on file |
| Tamir S. Ben-Hur, MD, PhD (Hadassah Hebrew University Medical Center) | The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kadimastem. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sipnose. The institution of Dr. Ben-Hur has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regenera Pharma. The institution of Dr. Ben-Hur has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medasense. Dr. Ben-Hur has received stock or an ownership interest from Sipnose. Dr. Ben-Hur has received stock or an ownership interest from Kadimastem. Dr. Ben-Hur has received stock or an ownership interest from MAPI Pharma. Dr. Ben-Hur has received intellectual property interests from a discovery or technology relating to health care. |
| Eldad Melamed, MD (Rabin Medical Ctr Beilinson Campus) | No disclosure on file |
| Dimitrios Karussis, MD, PhD (Hadassah HMO) | Prof. Karussis has nothing to disclose. |